The costs and benefits of deep brain stimulation in Parkinson's disease: a review and social network analysis

The costs and benefits of deep brain stimulation in Parkinson's disease: a review and social network analysis

Saved in:

Bibliographic Details
Main Authors:	Carlos Zúñiga-Ramírez, Katia Carmina Farías-Moreno, Gabriel Moreno, Enrique Gómez-Figueroa, Hernando Efraín Caicedo-Ortíz, José Damián Carrillo-Ruíz
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2025-07-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	Parkinson Disease Levodopa Deep Brain Stimulation Cost-Effectiveness Analysis Cost-Benefit Analysis
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1809996
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A comprehensive review of deep brain stimulation for Parkinson's disease: The history, current state of the art and future possibilities
by: Avery Foote, et al.
Published: (2025-06-01)

Continuous Dopaminergic Stimulation-Based Levodopa Treatment in Patients with Early to Mid-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis
by: Rong Tang, et al.
Published: (2025-05-01)

Pain in Parkinson's disease Dor na doença de Parkinson
by: Grace Helena Letro, et al.
Published: (2009-09-01)

Who benefits from fleet electrification? quantifying the costs and benefits of transportation electrification strategies from different perspectives
by: J.Andrew Kelly, et al.
Published: (2025-07-01)

Inefficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease Patients with Levodopa-Induced Dyskinesias: Results from a Pilot Study
by: Alma Medrano-Hernández, et al.
Published: (2025-07-01)

Medication versus globus pallidus internus deep brain stimulation in Parkinson’s disease with deep learning video analysis of finger tapping
by: Grace Yoojin Lee, et al.
Published: (2025-05-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

How I treat Parkinson's disease
by: Egberto Reis Barbosa, et al.
Published: (2022-08-01)

Hyponatremia in Parkinson’s Disease: The Impact of Carbidopa-Levodopa Therapy
by: Elizabeth Schumacher, et al.
Published: (2025-06-01)

COST BENEFIT ANALYSIS OF COMPROMISING LEDGER SYSTEM BASED ON BLOCKCHAIN TECHNOLOGY
by: Edis Mekić, et al.
Published: (2018-12-01)

Contribution of dopaminergic polymorphisms to levodopa treatment response and drug concentration in Chinese patients with Parkinson’s disease
by: Xiaoqin He, et al.
Published: (2025-01-01)

Bereitschaftspotential preceding eyelid blinks in Parkinson’s disease
by: Isabella Araújo Mota, et al.

Cost-benefit analysis and sustainability considerations in starting a restaurant: A case study from Sri Lanka
by: Sahan Perera, et al.
Published: (2025-06-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
by: Sebastiano Gangemi, et al.
Published: (2003-01-01)

Tratamento da doença de Parkinson
by: Francisco Cardoso
Published: (1995-03-01)

A Practical Framework and Model for Promoting Cost-Inclusive Evaluations
by: Nadini Persaud
Published: (2018-04-01)

COST-BENEFIT ANALYSIS OF TRANSITION TO ELECTRIC VEHICLES IN A LOGISTICS COMPANY
by: Mihaela STET
Published: (2024-12-01)

Cost-benefit Analysis of Earthquake Costs and Building Retrofitting Costs in Iran
by: Fariborz Mohammadi, et al.
Published: (2025-04-01)

Implementing a Streamlined Hypoglossal Nerve Stimulator Pathway: Cost, Time to Surgery, and Outcomes
by: Nicholas R. Lenze, et al.
Published: (2024-10-01)

Identification of electromyographic patterns of bradykinesia in patients with Parkinson's disease
by: Nikita Kozulin, et al.
Published: (2024-10-01)

Cost-benefit and equity analysis of nature-based solutions in Haiti, India, Indonesia and Uganda
by: Marta Vicarelli, et al.
Published: (2024-12-01)

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
by: Bruno Lopes SANTOS-LOBATO, et al.
Published: (2020-04-01)

Prosody and levodopa in Parkinsons disease
by: Luciana Lemos de Azevedo, et al.
Published: (2013-11-01)

On the linkage analysis modle of the telecom companies’ investment benefit
by: Bing XU
Published: (2017-09-01)

Specificity and sensibility of 9-Itens Wearing-off Questionnaire in Brazilian Parkinson disease patient sample
by: Jasper Guimarães Santos, et al.
Published: (2014-11-01)

An environmental cost-benefit analysis of organic and non-organic sheep farming in Iceland
by: Vincent Elijiah Merida, et al.
Published: (2024-12-01)

Working memory in Parkinson's disease patients: clinical features and response to levodopa Memória de trabalho em pacientes com doença de Parkinson: características clínicas e resposta a levodopa
by: Rogério Beato, et al.
Published: (2008-06-01)

Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation Escala para qualidade de vida na doença de Parkinson - PDQ 39 (versão do Português falado no Brasil) como instrumento para avaliação de pacientes com e sem flutuação motora decorrente da levodopa
by: Renata Guzzo Souza, et al.
Published: (2007-09-01)

Levodopa-induced motor complications associated with benserazide and carbidopa in Parkinson’s disease: a disproportionality analysis of the FAERS database
by: Huaide Qiu, et al.
Published: (2025-03-01)

Integral Cost-Benefit Analysis of Maglev Rail Projects Under Market Imperfections
by: J. Paul Elhorst, et al.
Published: (2008-07-01)

Integral Cost-Benefit Analysis of Maglev Rail Projects Under Market Imperfections
by: J. Paul Elhorst, et al.
Published: (2008-07-01)

Cost-benefit analysis of craniocerebral surgical site infection control in tertiary hospitals in China
by: Jiong Zhou, et al.
Published: (2015-02-01)

Respiratory changes in Parkinson's disease may be unrelated to dopaminergic dysfunction
by: Luciana Ulhôa Guedes, et al.
Published: (2012-11-01)

A case of Frégoli syndrome following 24-hour levodopa-carbidopa intestinal gel infusion in a patient with Parkinson’s disease undergoing STN-DBS
by: Shunsuke Ogata, et al.
Published: (2025-01-01)

Symptom improvement in a South Asian patient with Parkinson’s disease treated with immediate- and extended-release carbidopa–levodopa: a case report
by: Gail Reiner, et al.
Published: (2025-07-01)

An Introduction to Economic Analysis of Pest Management: A Case Study of Nematode Management
by: Yi Li, et al.
Published: (2025-02-01)

Efficacy and motor complications of original and generic levodopa in Parkinson&#39;s disease treatment
by: Kasemsap N, et al.
Published: (2016-05-01)

MANAGEMENT, BUDGETING AND COST-BENEFIT ANALYSIS: OPERATIONAL AND STRATEGIC ASPECT
by: Pavel P. Kholodov, et al.
Published: (2016-08-01)

Methodological Accounting of the Ecosystem Services Benefits of Community-based Restoration
by: Sony Baral, et al.
Published: (2025-01-01)